Delivery Devices at Lilly – Evolution and Future Trends

27 September 2022 16:40 - 17:10

Drug-Device integration and interactions

  • Container-Closure/Device interface
  • Tissue/Needle interface
Current challenges and potential pathways
  • High dose delivery
  • Large volume injections
  • Injection tolerability
  • Delivery/device preference
Concluding remarks and a look into the future

Drug delivery is a complex subject that requires the interdisciplinary engagement of various science and technology functions as well as the discipline of project management to effectively drive the development and commercialization of drug-device combination products to the market.

Karthik Vaideeswaran, Associate Vice President, DDCS (Delivery, Device and Connected Solutions), Eli LIlly